IMCR (STOCKS)
Immunocore Holdings plc American Depositary Shares
$34.200000
-0.540000 (-1.55%)
Prev close: $34.740000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Bahija Jallal
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,887.13M
- Employees
- 493
- P/E (TTM)
- —
- P/B (TTM)
- 4.28
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $430.78M |
| Benefits Costs and Expenses | $433.51M |
| Cost Of Revenue | $4.74M |
| Costs And Expenses | $433.51M |
| Gross Profit | $426.04M |
| Operating Expenses | $448.62M |
| Selling, General, and Administrative Expenses | $164.16M |
| Research and Development | $284.45M |
| Operating Income/Loss | -$22.58M |
| Income/Loss From Continuing Operations After Tax | -$18.07M |
| Income/Loss From Continuing Operations Before Tax | -$2.73M |
| Income Tax Expense/Benefit | $15.34M |
| Net Income/Loss | -$18.07M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$18.07M |
| Net Income/Loss Available To Common Stockholders, Basic | -$18.07M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.36 |
| Diluted Earnings Per Share | -$0.37 |
| Basic Average Shares | 101,354,938 |
| Diluted Average Shares | 103,389,889 |
| Assets | $1.12B |
| Current Assets | $1.05B |
| Inventory | $7.79M |
| Other Current Assets | $1.04B |
| Noncurrent Assets | $68.38M |
| Fixed Assets | $12.86M |
| Other Non-current Assets | $55.52M |
| Liabilities | $699.62M |
| Current Liabilities | $235.20M |
| Accounts Payable | $26.32M |
| Wages | $9.13M |
| Other Current Liabilities | $199.75M |
| Noncurrent Liabilities | $464.43M |
| Equity | $419.80M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $419.80M |
| Liabilities And Equity | $1.12B |
| Net Cash Flow From Operating Activities | -$34.96M |
| Net Cash Flow From Operating Activities, Continuing | -$34.96M |
| Net Cash Flow From Investing Activities | $7.81M |
| Net Cash Flow From Investing Activities, Continuing | $7.81M |
| Net Cash Flow From Financing Activities | $23.29M |
| Net Cash Flow From Financing Activities, Continuing | $23.29M |
| Exchange Gains/Losses | $849.00K |
| Net Cash Flow | -$3.01M |
| Net Cash Flow, Continuing | -$3.86M |
| Comprehensive Income/Loss | -$25.79M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$25.79M |
| Other Comprehensive Income/Loss | -$2.26M |